XETRA - Delayed Quote EUR
Novavax, Inc. (NVV1.DE)
7.85
-0.04
(-0.53%)
At close: February 17 at 5:35:45 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 5 | 5 |
| Avg. Estimate | 148.83M | 114.67M | 1.02B | 566.57M |
| Low Estimate | 68.5M | 35M | 838.26M | 324.26M |
| High Estimate | 198M | 234M | 1.26B | 996.5M |
| Year Ago Sales | 415.48M | 84.51M | 682.16M | 1.02B |
| Sales Growth (year/est) | -64.18% | 35.68% | 49.18% | -44.33% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NVV1.DE | -- | -- | -- | -- |
| S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | JP Morgan: Underweight to Underweight | 5/9/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/12/2024 |
| Reiterates | B. Riley Securities: Buy to Buy | 8/12/2024 |
| Maintains | JP Morgan: Underweight to Underweight | 8/12/2024 |
Related Tickers
88Q.DE 4basebio PLC
13.00
0.00%
7V0.DE Darwin AG
28.20
0.00%
BIO.DE Biotest Aktiengesellschaft
42.60
-0.47%
BIO3.DE Biotest Aktiengesellschaft
30.00
0.00%
9VC.DE Atai Life Sciences N.V.
1.2630
+0.44%
VX1.DE Vertex Pharmaceuticals Incorporated
372.85
-4.85%
AYJ.DE Valneva SE
2.9200
+0.14%
NP5.DE Newron Pharmaceuticals S.p.A.
8.84
+2.08%
HPHA.DE Heidelberg Pharma AG
3.1200
-1.58%
BBZA.DE BB Biotech AG Ord
30.15
-1.95%